IRIS PubliCatt

Morganti, Alessio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.278
NA - Nord America 6.456
AS - Asia 2.220
AF - Africa 73
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 15
Totale 16.079
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.341
DE - Germania 3.162
SE - Svezia 1.320
CN - Cina 975
SG - Singapore 632
UA - Ucraina 628
IT - Italia 571
IE - Irlanda 332
FR - Francia 288
GB - Regno Unito 266
ID - Indonesia 215
FI - Finlandia 195
IN - India 158
PL - Polonia 148
RU - Federazione Russa 130
CA - Canada 109
TR - Turchia 103
BE - Belgio 74
CI - Costa d'Avorio 65
CZ - Repubblica Ceca 52
JP - Giappone 37
IR - Iran 32
NL - Olanda 31
HK - Hong Kong 24
VN - Vietnam 16
AU - Australia 12
EU - Europa 12
RO - Romania 11
ES - Italia 10
LT - Lituania 9
CH - Svizzera 7
CL - Cile 7
EG - Egitto 6
PT - Portogallo 6
AT - Austria 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GR - Grecia 4
IL - Israele 4
LK - Sri Lanka 4
AR - Argentina 3
BR - Brasile 3
DK - Danimarca 3
HR - Croazia 3
HU - Ungheria 3
MX - Messico 3
MY - Malesia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
A1 - Anonimo 2
AL - Albania 2
EC - Ecuador 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 16.079
Salva come PNG Salva come JPEG
Città #
Chandler 1.538
Singapore 503
Ashburn 496
Jacksonville 385
Dublin 330
San Mateo 310
Nanjing 230
Dearborn 216
Ann Arbor 215
Jakarta 213
Wilmington 192
Nürnberg 183
Woodbridge 153
New York 149
Boston 147
Warsaw 145
Milan 131
Bremen 127
Marseille 118
Lawrence 103
Beijing 102
Izmir 101
Nanchang 92
Cattolica 89
Princeton 85
Moscow 84
Houston 80
Fairfield 77
Munich 77
Helsinki 75
Brussels 74
Redwood City 71
Abidjan 65
Leawood 61
Rome 61
Seattle 60
Los Angeles 51
Toronto 48
Zhengzhou 44
North York 42
Boardman 41
University Park 39
Kunming 37
Hebei 36
Shenyang 36
Jiaxing 35
Augusta 34
Fremont 32
Changsha 29
Tianjin 29
Phoenixville 28
Cambridge 27
Mountain View 26
Norwalk 26
Detroit 24
Lancaster 24
Auburn Hills 23
Hangzhou 22
Brno 21
Pune 21
Shanghai 21
Guangzhou 20
Washington 19
Falls Church 18
London 17
Redmond 16
Amsterdam 15
Hanoi 15
Monmouth Junction 15
Frankfurt am Main 14
Edinburgh 13
Lanzhou 13
Enterprise 12
Hong Kong 12
Andover 11
Hefei 11
Jinan 11
Ottawa 10
Ardabil 9
Chicago 9
Falkenstein 9
Indiana 9
San Francisco 9
Wuhan 9
Dresden 8
Sacramento 8
Bari 7
Bologna 7
Central District 7
Costa Mesa 7
Ningbo 7
Sergii 7
Simi Valley 7
Tokyo 7
Arezzo 6
Berlin 6
Kish 6
Landshut 6
Mumbai 6
Phoenix 6
Totale 8.338
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 797
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 254
A National project for in vivo dosimetry procedures in radiotherapy: First results 252
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 247
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 174
A National project for in vivo dosimetry procedures in radiotherapy: First results 172
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 168
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 166
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 162
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 149
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 146
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 144
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 140
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 139
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 139
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 138
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 138
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 136
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 133
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 131
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 131
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 130
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 130
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 129
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 129
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 129
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 129
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 128
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 128
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 128
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 125
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 122
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 122
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 121
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 119
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 116
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 116
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 116
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 113
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 113
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 112
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 111
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 111
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 111
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 111
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 111
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 110
In Vivo Portal Dosimetry by an Ionization Chamber 108
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 108
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 108
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 106
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 104
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 103
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 102
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 102
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 101
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 100
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 100
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 100
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 100
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 100
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 100
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 97
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 97
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 97
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 96
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 96
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 94
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 94
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 94
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 93
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 92
Real time transit dosimetry for the breath-hold radiotherapy technique experience 89
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 89
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 89
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 88
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 87
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 86
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 86
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 86
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 85
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 85
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 85
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 85
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 85
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 83
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 83
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 82
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 82
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 82
Preoperative chemoradiation with raltitrexed (Tomudex) in T2/N+ and T3/N+ rectal cancers: a phase I study. 80
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 79
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 77
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 77
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 77
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 77
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 77
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 75
Totale 12.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.464 0 0 0 0 0 223 298 136 216 163 265 163
2020/20211.452 81 171 30 156 204 64 140 42 167 107 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/20251.113 107 98 253 141 430 84 0 0 0 0 0 0
Totale 16.753